Ozempic Linked With Lower Dementia Risk, Nicotine Use, British Study Finds (Reuters) - Novo Nordisk's popular diabetes treatment Ozempic could be tied to a lower risk of cognitive problems ...
Semaglutide, the main active ingredient in Ozempic, is linked to a lower risk of cognitive decline in a new study. The study only focused on patients with type 2 diabetes. Doctors say there may be ...
Diabetic study participants were less likely to develop cognitive deficits on Ozempic than other diabetes medications. Ozempic was also linked to a lower likelihood of smoking. The study found ...
Novo Nordisk A/S’s Ozempic was linked to lower rates of dementia and a range of other mental problems in a University of Oxford study that raises expectations about the diabetes drug’s ...
SALT LAKE CITY — A class of drugs that's been hailed for weight loss and diabetes care also appears to protect the brain from ...
“A recent study conducted by the University of Oxford revealed that participants who used Semaglutide (the main ingredient in ...
The research adds to growing recognition that infectious agents may play a role in the development of some types of dementia.
(Reuters) - Novo Nordisk's popular diabetes treatment Ozempic could be tied to a lower risk of cognitive problems, according to an observational study published by researchers at Oxford University.